Key facts
- This page summarizes Alexander Dimitrief's Form 4 filing for Sotera Health Co (SHC).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 04 Mar 2025, 20:34.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 17,135 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.
Footnote F2
These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026.
Footnote F3
These securities consist of 90,323 RSUs and 244,402 shares of Common Stock that have vested.
Footnote F4
These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.
Footnote F5
No transaction is being reported on this line. Reported on a previously filed Form 4.
Footnote F6
These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.
Footnote F7
These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in two equal installments on each of October 31, 2023 and October 31, 2024, subject to the Reporting Person's continued service through each such date.
SEC remarks
The Power of Attorney for Mr. Dimitrief is filed as an exhibit to the Form 3 filed on November 8, 2022, which is hereby incorporated by reference.